NovoCure (NASDAQ:NVCR) reported its Q1 earnings results on Thursday, April 28, 2022 at 06:00 AM.
Here's what investors need to know about the announcement.
Earnings
NovoCure beat estimated earnings by 77.78%, reporting an EPS of $-0.04 versus an estimate of $-0.18.
Revenue was up $2.85 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.15 which was followed by a 3.13% increase in the share price the next day.
Here's a look at NovoCure's past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.10 | -0.07 | 0.01 | 0.02 |
| EPS Actual | -0.25 | -0.13 | -0.14 | -0.04 |
| Revenue Estimate | 135.42M | 141.76M | 141.89M | 139.36M |
| Revenue Actual | 133.21M | 133.61M | 133.52M | 134.69M |
To track all earnings releases for NovoCure visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
